Digital Ads And Mainers Call On Senator Collins To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
MAINE — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Maine today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Mainers thank Senator Susan Collins for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Collins has a real opportunity to advance common sense solutions that will deliver relief to Mainer patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Collins to act now.”
Below is an example of a digital ad running in Maine:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Maine, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Collins to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Alaskans Call On Senator Murkowski To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
ALASKA — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Alaska today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Alaskans thank Senator Lisa Murkowski for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Murkowski has a real opportunity to advance common sense solutions that will deliver relief to Alaskan patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Murkowski to act now.”
Below is an example of a digital ad running in Alaska:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Alaska, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Murkowski to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And People In Utah Call On Senator Lee To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
UTAH — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Utah today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which people in Utah thank Senator Mike Lee for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Lee has a real opportunity to advance common sense solutions that will deliver relief to patients in Utah through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Lee to act now.”
Below is an example of a digital ad running in Utah:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Utah, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), and Ted Cruz (TX).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Lee to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Louisianians Call On Senator Cassidy To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
LOUISIANA — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Louisiana today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Louisianians thank Senator Bill Cassidy for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Cassidy has a real opportunity to advance common sense solutions that will deliver relief to Louisianian patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Cassidy to act now.”
Below is an example of a digital ad running in Louisiana:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Louisiana, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Cassidy to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And North Dakotans Call On Senator Cramer To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
NORTH DAKOTA — Patients For Affordable Drugs Now (P4ADNow) launched new ads in North Dakota today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which North Dakotans thank Senator Kevin Cramer for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Cramer has a real opportunity to advance common sense solutions that will deliver relief to North Dakotan patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Cramer to act now.”
Below is an example of a digital ad running in North Dakota:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to North Dakota, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Cramer to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Floridians Call On Senator Scott To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
FLORIDA — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Florida today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Floridians thank Senator Rick Scott for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senator Scott has a real opportunity to advance common sense solutions that will deliver relief to Floridian patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senator Scott to act now.”
Below is an example of a digital ad running in Florida:
The campaign also includes TV video ads running in Washington, D.C. that feature two patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package.
In addition to Florida, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senator Scott to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Texans Call On Senators Cornyn And Cruz To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
TEXAS — Patients For Affordable Drugs Now (P4ADNow) launched new ads in Texas today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes digital ads and grassroots advocacy, through which Texans thank Senators John Cornyn and Ted Cruz for fighting to lower drug prices by ensuring the passage of a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and promote generic and biosimilar competition.
“Now that the Senate is back from recess, Senators Cornyn and Cruz have a real opportunity to advance common sense solutions that will deliver relief to Texan patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge Senators Cornyn and Cruz to act now.”
Below are examples of digital ads running in Texas:
The campaign also includes TV video ads running in Washington, D.C. that feature two Texas patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass the bipartisan competition bill package. The first ad features Jacqueline Garibay, a college student and patient advocate who lives with ankylosing spondylitis, an autoimmune disorder that affects most of her major joints. The second adfeatures Lisa McRipley, a Richmond, Texas patient who lives with multiple sclerosis.
In addition to Texas, P4ADNow’s campaign includes digital ads and grassroots advocacy in nine additional states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), and Mike Lee (UT).
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum by urging Senators Cornyn and Cruz to pass legislation to lower drug prices for patients.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
Digital Ads And Hoosiers Call On Senator Braun To Pass Bipartisan Legislation To Curb Big Pharma Abusive Monopolies And Boost Lower Cost Generic Competition
WASHINGTON, D.C — Patients For Affordable Drugs Now (P4ADNow) launched a six-figure ad campaign today as part of its “Push For Competition To Lower Drug Prices.” The campaign includes two video ads featuring patients who are forced to struggle with the high prices of their prescription drugs and urgently call on the Senate to pass a package of bipartisan bills that crack down on the drug industry’s anti-competitive practices and close regulatory loopholes to promote generic and biosimilar competition to lower drug prices for patients. Jacqueline Garibay is a college student who lives with ankylosing spondylitis, and Lisa McRipley lives with multiple sclerosis. The 30-second videos are running on digital and TV platforms in Washington, D.C. The campaign also includes digital static ads as well as grassroots advocacy across ten states, through which people will call and write their senators to demand the timely passage of the competition bill package.
“Now that the Senate is back from recess, there is a real opportunity to advance common sense solutions supported by both Republicans and Democrats in the Senate that will deliver relief to patients through lower drug prices,” said David Mitchell, a patient with incurable blood cancer whose drugs carry a list price of more than $900,000 per year and founder of Patients For Affordable Drugs Now. “It’s time to curb drug companies’ abuse – through anti-competitive practices that extend monopolies beyond the time intended under law – and allow our system to work, with timely generic and biosimilar competition in the marketplace to lower prices. We urge the Senate to act now.”
The first ad features Jacqueline Garibay, a college student and patient advocate who lives with ankylosing spondylitis, an autoimmune disorder that affects most of her major joints. “The last time we had to buy my medication, I decided to forgo it. We just couldn’t afford $6,000 a month,” Jacqueline of Austin, Texas, says in the ad. “While my classmates are thinking about their careers, their weddings, all I can think about is how I’m going to afford my medication.”
Watch Jacqueline’s ad here.
The second ad features Lisa McRipley, a Richmond, Texas patient who lives with multiple sclerosis. “The medication to treat my MS is nearly $7,500 a month. But without it, my disease will progress irreversibly – I could lose my independence solely because of outrageous drug prices,” Lisa, a medicare beneficiary, says in the ad. “Congress can fix this. We can’t afford to wait.”
Watch Lisa’s ad here.
P4ADNow’s campaign includes digital ads as well as grassroots advocacy in ten states, thanking the following senators for fighting to lower drug prices by ensuring competition: Lisa Murkowski (AK), Rick Scott (FL), Chuck Grassley (IA), Joni Ernst (IA), Mike Braun (IN), Bill Cassidy (LA), Susan Collins (ME), Josh Hawley (MO), Kevin Cramer (ND), John Cornyn (TX), Ted Cruz (TX), and Mike Lee (UT).
See example ads here:
Over the summer, 35 organizations representing patients, consumers, seniors, churches, students, unions and disease advocacy groups sent a letter to the Senate to pass bipartisan patent and regulatory reforms that curb abuses and allow greater competition to lower drug prices. This campaign builds on this momentum.
###
Patients For Affordable Drugs Now is the only national patient advocacy organization that focuses exclusively on system-changing policies to lower drug prices. P4ADNow is independent, bipartisan and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.
